Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 5.07MCapital Expenditure
VS
Market
Sector
Industry
History
$ 2.11Close
$ 1.1 - $ 5.94 52-Week Range
Ticker Information
Ticker
TCRXCompany Name
TSCAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQTSCAN THERAPEUTICS INC - Capital Expenditure Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TCRX - CapEx Historical data
| Date | Capital Expenditure |
|---|---|
| 6/30/2025 | $ 5.07M |
| 3/31/2025 | $ 4.65M |
| 12/31/2024 | $ 3.83M |
| 9/30/2024 | $ 3.41M |
| 6/30/2024 | $ 3.46M |
| 3/31/2024 | $ 3.01M |
| 12/31/2023 | $ 3.15M |
| 9/30/2023 | $ 4.05M |
| 6/30/2023 | $ 3.06M |
| 3/31/2023 | $ 4.53M |
Key Performance Insights, Last 5 Years
- TSCAN THERAPEUTICS INC's latest trailing twelve months (TTM) CapEx stands at $ 4.24M.
- Over the past 5 years, TSCAN THERAPEUTICS INC's average CapEx has been $ 4.67M.
- The median CapEx for TSCAN THERAPEUTICS INC during this period was $ 4.23M
- TSCAN THERAPEUTICS INC reached its highest CapEx over the past 5 years at $ 9.94M.
- The lowest CapEx recorded by TSCAN THERAPEUTICS INC in the same timeframe $ 3.01M
TSCAN THERAPEUTICS INC's CapEx vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
CapEx Benchmarks
Similar metrics to CapEx:
- Capital Expenditures Margin - [Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
- Capital Expenditures Coverage - [Calculation] The Capital Expenditure Ratio, or capex coverage, describes the ability of a business to generate enough cash from day-to-day operations to cover capital expenditures. It is calculated by dividing the cash flow from operations [NCFO] by its capital expenditures [CapEx].
- Capital Expenditures to Operating Cash Flow - [Calculation] The CapEx to Operating Cash Flow ratio, measures how much of a company’s operating cash flow is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by net operating cash flow [NCFO].
- Free Cash Flow - [Calculation] Free Cash Flow is a metric that measures the cash that remains after a company pays its operating expenses [OpEx] and capital expenditures [CapEx]. It can be calculated as Net Cash Flow from Operations [NCFO] minus capital expenditures.
- Property Plant & Equipment (Net) - [Balance Sheet] A component of [Assets] representing the assets that are either property, plant or equipment after accumulated depreciation, depletion and amortization. Common examples include buildings, land, furniture, and other physical assets that a company has purchased to run its business.
Definition of Capital Expenditure
[Cash Flow Statement] CapEX, also know as capital expenditures, is a component of investing cash flow [NCFI] that refers to funds that are used to acquire, improve or maintain long-term assets [AssestsNC] of the company. Capital expense may include the purchase of new equipment, machinery, buildings or warehouses, furniture, software or intangibles such as intellectual property.TCRX - Capital Expenditure, Last 5 years
$ 3.01M
Minimum
Mar 31, 2024
$ 9.94M
Maximum
Dec 31, 2021
$ 4.67M
Average
$ 4.23M
Median
CapEx Benchmark AnalysisMarket
The chart above depicts the distribution of CapEx for companies in the Total Stock Market. The average CapEx of the companies is $ 9.73M with a standard deviation of $ 15.95M.
The following table provides additional summary stats:
CapEx in the Market:
| filtered constituents | 2.92K |
|---|---|
| min | $ -41.06M |
| max | $ 63.95M |
| average | $ 9.73M |
| median | $ 1.95M |
| std | $ 15.95M |